But to a lesser degree and perhaps shorter lasting timeframe
Pfizer passed the final hurdle of meeting the safety requirements to apply for emergency-use approval, but the announcement also came with a bit of an attempt to try and one up Moderna as they claim that their vaccine is 95% effective upon final analysis.

Latest data from the Mortgage Bankers Association for the week ending 13 November 2020
–  -0.5%
– Market index 831.5 vs 833.9 prior
– Purchase index 303.9 vs 293.5 prior

Pfizer plans to file for emergency-use authorisation from the FDA
– Vaccine shown to be 95% effective in final efficacy analysis of Phase 3 trial
– Plans to file for emergency-use authorisation within days
Risk trades are getting another shot in the arm on the news here, albeit a more modest one this time around. European stocks are

Remarks by UK medical adviser, Susan Hopkins

The OPEC+ JMMC meeting yesterday ended with no formal recommendation